MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3389/fonc.2025.1617457

Медицинская библиотека · Frontiers in oncology · 2025

Case Report: Malignant peritoneal mesothelioma with TFG-ROS1 fusion responds to crizotinib.

Ye Wei, Li Peng, Fu Cong, Zhou Tong

Клинический случайСтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

Malignant peritoneal mesothelioma (MPM) is an exceptionally rare tumor type, and its molecular properties are poorly understood. In recent years, gene rearrangement has been found in a subset of MPMs. However, ROS1 rearrangement has not been previously reported in MPM.

CASE PRESENTATION: Here, we present the first case report of MPM with TFG-ROS1 rearrangement in a 56-year-old female with no history of asbestos exposure. The patient did not respond to immunotherapy but exhibited sensitivity to crizotinib with a progression-free survival (PFS) of 6 months. Importantly, we identified ROS1 p.K1991N as a potential acquired drug resistance mutation to crizotinib, suggesting that entrectinib may serve as a targeted therapy to overcome this resistance mechanism.

CONCLUSION

ROS1 rearrangement could potentially represent a novel driver mutation in MPM, especially in female adults. This case report illustrates the benefits of molecular detection in MPM and underscores the potential for lessons learned from other solid tumors to inform treatment strategies for rare diseases.

Для цитирования: Ye Wei, Li Peng, Fu Cong, Zhou Tong. Case Report: Malignant peritoneal mesothelioma with TFG-ROS1 fusion responds to crizotinib.. Frontiers in oncology. 2025. DOI: 10.3389/fonc.2025.1617457.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.